Bruker's Q4 Revenues Climb 14 Percent
February 23, 2011
Bruker's Q4 Revenues Climb 14 Percent
The company's scientific instruments segment saw revenues increase 13 percent year over year, while Bruker Energy & Supercon Technologies, which filed for an IPO in September, saw a 23 percent jump in revenues.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Bruker Q4 Revenues up 9 Percent; Job Cuts Ahead
February 19, 2013 / GenomeWeb Daily News - UPDATE: Q2 Revenues Spike 19 Percent for Bruker
July 28, 2010 / GenomeWeb Daily News - Bruker's Q1 Revenues Up 21 Percent
April 29, 2010 / GenomeWeb Daily News - Bruker Posts 16 Percent Q4 Revenue Growth, Surpasses Preliminary Results
February 25, 2010 / GenomeWeb Daily News - Triple Quads Take the Stage at ASMS 2013 as Vendors Continue Piecing Together Clinical MS Platforms
June 14, 2013 / ProteoMonitor